Total Payments
$1,571
2024 Payments
$50.06
Companies
10
Transactions
57
Medicare Patients
270
Medicare Billing
$28,990
Payment Breakdown by Category
Food & Beverage$1,565 (99.6%)
Education$6.02 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,565 | 56 | 99.6% |
| Education | $6.02 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $493.78 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $259.27 | 12 | $0 (2020) |
| Novo Nordisk Inc | $242.12 | 8 | $0 (2020) |
| Lilly USA, LLC | $172.49 | 5 | $0 (2022) |
| PFIZER INC. | $125.73 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $100.25 | 5 | $0 (2019) |
| Amgen Inc. | $71.70 | 3 | $0 (2019) |
| Circassia Pharmaceuticals Inc | $52.20 | 3 | $0 (2019) |
| Exact Sciences Corporation | $30.57 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $22.83 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.06 | 2 | Exact Sciences Corporation ($30.57) |
| 2022 | $14.67 | 1 | Lilly USA, LLC ($14.67) |
| 2020 | $142.18 | 8 | AstraZeneca Pharmaceuticals LP ($43.81) |
| 2019 | $341.87 | 13 | Novo Nordisk Inc ($162.98) |
| 2018 | $491.72 | 16 | AstraZeneca Pharmaceuticals LP ($188.09) |
| 2017 | $530.44 | 17 | Janssen Pharmaceuticals, Inc ($204.06) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: Oncology | ||||||
| 02/15/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Diabetes | ||||||
| 06/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 06/18/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/30/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Diabetes | ||||||
| 02/28/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Diabetes | ||||||
| 01/09/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $122.40 | General |
| Category: Diabetes | ||||||
| 09/04/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.83 | General |
| 08/15/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Diabetes | ||||||
| 06/18/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: DIABETES | ||||||
| 05/01/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2019 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 04/04/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Neuroscience | ||||||
| 03/19/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: DIABETES | ||||||
| 02/20/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Diabetes | ||||||
| 01/22/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 79 | 147 | $28,934 | $11,601 |
| 2022 | 5 | 106 | 128 | $19,393 | $8,133 |
| 2021 | 2 | 28 | 55 | $9,880 | $3,737 |
| 2020 | 3 | 57 | 105 | $16,556 | $5,518 |
Total Patients
270
Total Services
435
Medicare Billing
$28,990
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 111 | $24,444 | $9,084 | 37.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $4,275 | $2,389 | 55.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 17 | $215.00 | $128.80 | 59.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 47 | $10,595 | $4,152 | 39.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $4,197 | $2,339 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 23 | $3,945 | $1,272 | 32.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 17 | 17 | $527.00 | $301.58 | 57.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 21 | 23 | $130.00 | $68.19 | 52.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 35 | $5,363 | $2,207 | 41.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 20 | $4,517 | $1,531 | 33.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 49 | $11,067 | $3,558 | 32.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 35 | $5,363 | $1,897 | 35.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 15 | 21 | $126.00 | $62.94 | 50.0% |
About Dr. Ransky Allonce, M.D
Dr. Ransky Allonce, M.D is a General Practice healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2014. The National Provider Identifier (NPI) number assigned to this provider is 1770991010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ransky Allonce, M.D has received a total of $1,571 in payments from pharmaceutical and medical device companies, with $50.06 received in 2024. These payments were reported across 57 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,565).
As a Medicare-enrolled provider, Allonce has provided services to 270 Medicare beneficiaries, totaling 435 services with total Medicare billing of $28,990. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Clermont, FL
- Active Since 07/31/2014
- Last Updated 12/16/2025
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770991010
Products in Payments
- FARXIGA (Drug) $310.54
- BYDUREON (Drug) $183.24
- INVOKANA (Drug) $170.99
- Ozempic (Drug) $150.65
- PREVNAR - 13 (Biological) $125.73
- TRULICITY (Drug) $123.19
- Tresiba (Drug) $91.47
- JARDIANCE (Drug) $83.72
- XARELTO (Drug) $82.26
- TRADJENTA (Drug) $53.22
- TUDORZA PRESSAIR (Drug) $52.20
- Prolia (Biological) $47.44
- Cologuard Collection Kit (Device) $30.57
- Aimovig (Biological) $24.26
- BASAGLAR (Drug) $12.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Clermont
Fadi Rahhal, Md, MD
General Practice — Payments: $11,386
General Practice $11,386
Egle Skruodyte, Dmd, DMD
General Practice — Payments: $6,308
General Practice $6,308
Dr. Edwin Acosta, Dds, DDS
General Practice — Payments: $6,063
General Practice $6,063
Dr. Carlos Ortiz, D.d.s, D.D.S
General Practice — Payments: $3,626
General Practice $3,626
Nanette Ortiz, Md, MD
General Practice — Payments: $2,828
General Practice $2,828
Dr. Freddy Mezquia, Dmd, DMD
General Practice — Payments: $2,632
General Practice $2,632